EDublin, nge-12 ka-Okthobha, 2021/PRNewswire/-”I-Global Dermal Filler Market Forecast in 2028-COVID-19 Impact kunye noHlahlelo lweMveliso yeHlabathi (iBiodegradable and Non-biodegradable);Izixhobo;izicelo;Abasebenzisi bokugqibela kunye neJografi "Ingxelo yongezwe kwiimveliso zeResearchAndMarkets.com.
Ngo-2028, ixabiso lemarike ye-dermal fillers liya kunyuka ukusuka kwi-USD 4.39198 yezigidigidi kwi-2021 ukuya kwi-USD 9.421.3 yeebhiliyoni;Kuqikelelwa ukuba ukusuka ku-2021 ukuya ku-2028, izinga lokukhula kwayo ngonyaka li-11.5%.Ukukhula kwentengiso ye-dermal filler kubalelwa ikakhulu kukwanda kokukhetha utyando olungenabungozi, ukukhula kwabemi kwiqela leminyaka engama-30-65, kunye nomtsalane wabathengi kubuhle kunye nempilo.Nangona kunjalo, ixabiso eliphezulu lotyando lithintela ukukhula kwemarike.I-dermal filler yimveliso echasene nokuguga efakwe esikhumbeni sesigulana ukwandisa umthamo.Zitofe ukwenza ulusu olushwabeneyo okanye olushwabeneyo ngenxa yobudala lubukeke lugudile kwaye lutyebile.Zikwabizwa ngokuba zii-injectable facial fillers, ii-injectable cosmetic fillers okanye ii-soft tissue fillers.Zenziwe nge-hyaluronic acid ephuma kwisilwanyana okanye kwisigulane esinamafutha.Kuthatha imizuzu emihlanu ukuya kwiyure ukwenza inkqubo yedermal filler.Iifayili ze-Intradermal zingasetyenziselwa kwi-dermatological practice kunye neendleko ezincinci zokulawula.Basombulula iingxaki zokulahleka komthamo wobuso kunye nemigca eguquguqukayo, ezo ziyimpawu eziphambili zokuguga kobuso.Banikezela ngoluhlu lweendlela zonyango eziguquguqukayo kwiidermatologists ukufikelela kwiziphumo ezilinganayo kunye nezipheleleyo.Imakethi ye-dermal filler yahlulwe ngokweemveliso, izixhobo, usetyenziso, kunye nabasebenzisi bokugqibela.Ngemveliso, imakethi ye-dermal filler yahlulwe ibe yi-biodegradable kwaye i-non-biodegradable.Icandelo lemakethi ye-biodegradable kulindeleke ukuba lithathe isabelo esikhulu semakethi ngo-2021, kwaye kulindeleke ukuba lirekhode inqanaba lokukhula elihlanganisiweyo lonyaka ngexesha loqikelelo.Ngokwezixhobo, imakethi ye-dermal filler yahlulwe yaba yi-calcium hydroxyapatite, i-hyaluronic acid, i-collagen, i-poly-L-lactic acid, i-polymethyl methacrylate (PMMA), amafutha kunye nezinye izinto.Kuqikelelwa ukuba ngo-2021, icandelo le-hyaluronic acid liya kuthatha esona sabelo sikhulu semarike, kwaye icandelo le-collagen kulindeleke ukuba libe nelona zinga liphezulu lokukhula lonyaka ngexesha lokuqikelela.
Ngokwesicelo, imakethi ye-dermal filler yahlulwe yaba kunyango lokulungiswa kobuso, ukuphuculwa kwemilebe, utyando lweplastiki, unyango lwezilonda, njl. njl. icandelo kulindeleke ukuba libe nelona zinga liphezulu lokukhula konyaka ngexesha loqikelelo.Ngokwabasebenzisi bokugqibela, imakethi yedermal filler yahlulwe yaba ziikliniki zedermatology, izibhedlele ezikhethekileyo, kunye namaziko otyando ngaphandle.Icandelo leklinikhi yedermatology lingathatha esona sabelo sikhulu semarike ngo-2021. Kwelinye icala, icandelo lezibhedlele ezikhethekileyo ezininzi kulindeleke ukuba libe nelona zinga liphezulu lokukhula lonyaka ngexesha loqikelelo.Isizathu sokuthenga
Ngokuchonga ukukhula, ubungakanani, abadlali abakhokelayo kunye namacandelo emarike yentengiso yedermal fillers, gcina kwaye unciphise ixesha lokuqhuba uphando lwenqanaba lokungena.
Gxininisa izinto eziphambili kwishishini ukunceda inkampani ilungelelanise isicwangciso sayo soshishino.
Ezona ziphumo ziphambili kunye nezindululo ziqaqambisa eyona ndlela iphambili yokuqhubela phambili kweshishini kwimakethi yehlabathi yedermal filler, ngaloo ndlela ivumela abathathi-nxaxheba kulo lonke ikhonkco lexabiso ukwenza izicwangciso ezisebenzayo zexesha elide.
Ukuqulunqa/ukuguqula izicwangciso zokwandisa ishishini ngokusebenzisa ukukhula okubonakalayo kwiimarike eziphuhlileyo nezikhulayo.
Uphononongo olunzulu lweentsingiselo kunye nezinto ezilindelekileyo kwimarike yehlabathi, kunye nezinto eziqhuba imakethi kwaye zithintele uphuhliso lwemarike.
Ukuphucula inkqubo yokwenza izigqibo ngokuqonda izicwangciso ezixhasa umdla wokhuseleko lomthengi kwimveliso, ulwahlulo, amaxabiso, kunye nokuhanjiswa.
Izihloko eziphambili ezihlanganisiweyo: 1. Intshayelelo 2. I-dermal filler market-key point 3. Indlela yophando 4. Global Dermal Fillers Market-Market Landscape 4.1 Overview 4.2 PEST Analysis 4.2.1 North America-PEST Analysis 4.2.2 Europe-PEST Analysis 4.2. 3 Uhlalutyo lwe-Asia Pacific-PEST 4.2.4 kuMbindi Mpuma kunye ne-Afrika (MEA)-PEST Uhlalutyo 4.2.5 I-Southern and Central America (SCAM)-PEST Uhlalutyo4.3 uluvo lwengcali5.Izinto ezitshintshayo kwimarike yezihluzi zedermal 5.1 Abaqhubi bemarike 5.1.1 Ukunyusa ukhetho lotyando olungephi 5.1.2 Ukwanda kwabemi abakwiqela leminyaka engama-30-65 5.1.3 Ukwandisa umtsalane wabathengi ngobuhle nempilo 5.2 Izithintelo zentengiso 5.2.1 Amaxabiso aphezulu iinkqubo zotyando 5.3 Amathuba emarike 5.3.1 Ukunyusa ingeniso enokulahlwa kunye nokwandisa abantu abakumgangatho ophakathi 5.4 Iintsingiselo zexesha elizayo 5.4.1 Imisebenzi yobuchule yabathathi-nxaxheba kwimarike 5.4.2 Ukunyusa izinga lokwamkelwa kwezithako ezitofwayo kuluntu lwamadoda 5.5 Uhlalutyo lwempembelelo 6. Imarike yokugcwaliswa kwedermal. -uhlalutyo lwehlabathi jikelele 6.1 Uqikelelo lwengeniso kunye nohlalutyo lwemalike yemalike yokugcwaliswa kwedermal 6.2 Imarike yehlabathi jikelele yokuzaliswa kwedermal, ngokwengqikelelo yendawo yejografi kunye nohlalutyo 6.3 Ubume beMarike 7. Uhlalutyo lweMarike yeDermal Filler-NgeMveliso 7.1 Ushwankathelo 7.2 ISabelo seMarike yeDermal Filler ngeMveliso (2021 kunye 2028) 7.3 Biodegradable 7.3.1 Overview 7.3.2 Biodegradable: Dermal Filler Market-By 2028 Revenue and Forecast (Million USD) 7.4 I-Non-Biodegradable 7.4.1 Overview 7.4.2 Non-Biodegradable: Dermal Filler Market-Revenue and Forecast in 2028 (Million USD)8.I-Dermal Filler Market Analysis-8.1 Overview by Material 8.2 Dermal Filler Market Revenue Share by Material (2021 and 2028) 8.3 Calcium Hydroxyapatite 8.3.1 Overview 8.3.2 Calcium Hydroxyapatite: Dermal Hydroxyapatite Market-Revenue and Forecast to 4.Million USD8 Acid 8.4.1 Overview 8.4.2 Hyaluronic Acid: Dermal Filler Market-Revenue and Forecast to 2028 (Million USD) 8.5 Collagen 8.5 .1 Overview 8.5.2 Collagen: Dermal Filler Market-Revenue and Forecast to 2028 (Million USD) 8. -L-lactic Acid 8.6.1 Overview 8.6.2 Poly-L-Lactic Acid: Dermal Filler Market- Ingeniso kunye noqikelelo kwi-2028 (izigidi zeedola) 8.7 Polymethyl methacrylate (PMMA) 8.7.1 Overview 8.7.2 Polymethyl methacrylate (PMMA) : Dermal filler market-revenue and revenue by 2028 Forecast (US$ million) 8.8 Fat fillers 8.8.1 Overview 8.8.2 Fat fillers: dermal fillers market-reference and forecast by 2028 (US$ million) 8.9 Ezinye izinto 8.9.1 Overview 8.9.2 Ezinye iimathiriyeli : Izigcwali zedermal-ingeniso yemarike kunye noqikelelo to 2028 (USD yeebhiliyoni zeebhiliyoni) 9. Imarike yokugcwaliswa kwedermal-ngesicelo 9.1 Isishwankathelo 9.2 Isabelo semarike sokuzaliswa kwedermal, ngesicelo, ngo-2021 no-2028 (%) 9.3 Unyango loLuleko loMlayini woBuso 9.3.1 Isishwankathelo 9.3.2 Unyango loLuleko loMlayini woBuso: Dermal I-Filler Market-Revenue and Forecast to 2028 (Million USD) 9.4 Ukwandiswa koMlebe 9.4.1 Overview 9.4.2 Ukwandiswa koMlebe: I-Deermal Filler Market-2028 Ingeniso yonyaka kunye noqikelelo (izigidi zeedola) 9.5 Ukuphakamisa ubuso 9.5.1 Umbono jikelele2 woBuso 9.5. lift: Dermal filler market-Ingeniso kunye noqikelelo ngo 2028 (Izigidi zeerandi) 9.6 Iscar unyango 9.6.1 Overview 9.6.2 Scar Treatment: Dermal Filler Market-Revenue and Forecast in 2028 (Million USD) 9.7 Ezinye izicelo 9.7.1 Overview 9.7. .2 Ezinye izicelo: iMarike yeDermal Filler-Ingeniso kunye ne-Forecast kwi-2028 (i-Million USD) 10. I-Dermal Fillers Market Market-10.1 Isishwankathelo nguMsebenzisi wokugqibela 10.2 iSabelo seMarike ye-Dermal Filler nguMsebenzisi wokugqibela, i-2021 kunye ne-2028 (%) 10.3 i-Multi-specialty Hospital Hospital 10.3.1 Isishwankathelo 10.3.2 I-Multi-specialty Hosi-pital: I-Market ye-Dermatology ye-Dermat-Ngo-2028 iNgeniso kunye ne-Forecast (i-Million USD) 10.4 iKliniki ye-Dermatology 10.4.1 Isishwankathelo 10.4.2 I-Dermatology Clinic: i-Deermal Filler Market-Ingeniso kunye ne-Forecast kwi-2028 (i-Million USD) 10.5 i-Outpatient Surgery Centre.10 Overview0 Centre.5 .2 Iziko loTyando lwezigulana zangaphandle: iMarike yeDermal Filler-Ingeniso kunye noQoqosho lwe-USD 2028 (iMillion ye-USD) 10.6 Abanye abasebenzisi beSiphelo 10.6.1 Isishwankathelo 10.6.2 Abanye abasebenzisi: Ingeniso yeMarike ye-Dermal Filler kunye neForecast ngo-2028 (izigidi ze-USD) 11. IMarike yeGlobal Dermal Fillers-Geographical Analysis 12. Impembelelo yobhubhane we-COVID-19 kwimarike yehlabathi yokuzalisa idermal 12.1 kuMntla Melika: Uvavanyo lwempembelelo yobhubhane we-COVID-19 12.2 Yurophu: Uvavanyo lwempembelelo yobhubhane we-COVID-19 12.3 Asia Pacific : Uvavanyo lwempembelelo yobhubhani we-COVID-19 12.4 kuMbindi Mpuma kunye ne-Afrika: Uvavanyo lwempembelelo yobhubhani we-COVID-19 12.5 eMzantsi noMbindi Melika: Uvavanyo lwempembelelo yobhubhane we-COVID-13.Imbonakalo-mhlaba yemarike yemizi-mveliso yezihluzi zedermal 13.1 Isishwankathelo 13.2 Isicwangciso sokukhula kwemarike esiphunyezwe yinkampani, (%) 13.3 Uphuhliso lwendalo 13.3.1 Isishwankathelo 13.4 Uphuhliso lwe-Inorganic 13.4.1 Isishwankathelo 14. Iprofayile yeNkampani 14.1 AbbVie Inc. 14.1.1 Iinyaniso ezingundoqo. Inkcazo yoshishino 14.1.3 Iimveliso kunye neenkonzo 14.1.4 Isishwankathelo sezemali 14.1.5 Uhlalutyo lwe-SWOT 14.1.6 Uphuhliso oluphambili 14.2 Galderma 14.2.1 Iimpawu eziphambili 14.2.2 Iimveliso neenkonzo zoshishino Inkcazo 14.14.3 2.4 Uhlalutyo lwemali 14.2.5 Uhlalutyo lwemali 14.2.5 .6 Uphuhliso oluphambili 14.3 I-Merz Pharma 14.3.1 Amanqaku aphambili 14.3.2 Inkcazelo yoshishino 14.3.3 Iimveliso kunye neenkonzo 14.3.4 Isishwankathelo sezemali 14.3.5 Uhlalutyo lwe-SWOT 14.3.6 Uphuhliso oluphambili 14.4 Suneva Medical 14.2s141 Key F14.Inkcazelo yoShishino 14.4.3 IiMveliso neeNkonzo 14.4.4 Isishwankathelo sezeMali 14.4.5 Uhlalutyo lweSWOT 14.4.6 Uphuhliso oluPhambili 14.5 I-BIOXIS Pharmaceutical 14.5.1 Iinyaniso eziphambili 14.5.2 Inkcazelo yoShishino 14.5.3 IiMveliso neeNkonzo 14.5.4 Ushwankathelo lwezeMali. Uhlalutyo lwe-SWOT Uphuhliso oluPhambili 14.5.6 I-Huadong Pharmaceutical Co., Ltd. 14.6.1 Isishwankathelo esiPhambili 14.6.2 Inkcazo yoShishino 14.6.3 Iimveliso kunye neenkonzo 14.6.4 Isishwankathelo sezeMali 14.6.5 Uhlalutyo lwe-SWOT 14.6.6 Uphuhliso oluphambili 14.7 Parkson Biotech Co., Ltd. 14.7.1 K Zonke iinyani 14.7.2 Inkcazo yeshishini 14.7.3 Iimveliso kunye neenkonzo 14.7.4 Isishwankathelo semali 14.7.5 Uhlalutyo lwe-SWOT 14.7.6 Uphuhliso oluphambili 14.8 Ilabhoratri ye-TEOXANE8 1 Ilabhoratri ye-TEOXANE8. Iinyani 14.8.2 Inkcazo yoshishino 14.8.3 Iimveliso neenkonzo 14.8.85 Uhlalutyo lwemali 14.8.85 Isishwankathelo sohlalutyo lwemali Uphuhliso olungundoqo 14.9 Ilabhoratri ye-BIOHA 14.9.1 Amanqaku aphambili 14.9.2 Inkcazelo yoshishino 14.9.3 Iimveliso neenkonzo 14.9.4 Ushwankathelo lwezemali .5 Uhlalutyo lwe-SWOT 14.9.6 Uphuhliso oluPhambili 14.10 I-Prollenium Medical Technology 14.10.1 Iinyaniso eziphambili 14.13.1 Iimveliso kunye neenkonzo 14.14.10 10.4 Isishwankathelo sezeMali 14.10.5 Uhlalutyo lwe-SWOT 14.10.6 Uphuhliso oluphambili 15. Ulwazi malunga nesi sihlomelo seSihlomelo nceda undwendwele https://www.researchandmarkets.com/r/fjwmol
Research and Marketing Laura Wood, Senior Manager press@researchandmarkets.com US Eastern Time Office hours call +1-917-300-0470 US/Canada toll free number +1-800-526-8630 GMT Office hours call +353-1 -416 -8900 US Fax: 646-607-1904 Fax (Outside the US): +353-1-481-1716
Jonga umbhalo wokuqala: https://www.prnewswire.com/news-releases/insights-on-the-dermal-fillers-global-market-to-2028—by-product-material-application-end-user- kunye -ijografi-301398176.html
Nangona imakethi iqhutywa ziimvakalelo zexesha elifutshane eziphenjelelwa sisimo senzala e-United States, iindaba zentsholongwane kunye nenkcitho yovuselelo, abatyali mali abaninzi baqalisile ukulumka malunga nentengiso yenkomo yangoku ukusukela ngoMatshi ka-2020, ukubiyela okanye ukunciphisa uninzi lwentengiso. izikhundla zabo ezinde.Abanye abaphathi bengxowa-mali babheja kwiDow […]
Kubatyali-mali abafuna eyona mbuyekezo ingcono, isigqibo sokuba bazatyala phi utyalo-mali lwabo lokuqala ludla ngokuhla kwiinketho ezimbini.Beka onke amaqanda akho kwibhaskithi enkulu, uthenge iinkampani ezinkulu kwiimarike, ezo nkampani ze-trillion-dollar ezaziwa ngamaxabiso azo aphezulu kunye nokukhula okuzinzileyo-okanye ukuthenga okuphantsi, kwaye ufumane iqela leempahla eziphantsi kwexabiso eliphantsi kwinkampani. .Isiseko seshishini kunye namandla aphezulu aphezulu.Konke kuxhomekeke ekubeni ufuna imbuyekezo kangakanani.Intengiso
Njengoko iinkampani ezisisiseko zenza inkqubela phambili, ii-lithium stocks ezincinci zitsala umdla wabatyali-mali.
Faka isicelo se-American Express Platinum Card ngoku kwaye uyivume phambi ko-Okthobha 3, 2021, ukonwabela uphuculo lolwamkelo kunye nesaphulelo sokutya se-HK5000 xa ungena kunye netyala!
Iphothifoliyo yesitokhwe esihlawula isahlulo sibonelela nge-ballast yekamva eliqinileyo kwaye ivumela ukuba inxalenye encinci yemali yakho isetyenziselwe ukukhula kwesitokhwe kunye notyalo-mali olunomngcipheko ophezulu.Ngokumalunga nokwabelana ngobutyebi kunye nabatyalo-mali, i-Unilever (NYSE: UL), i-Altria Group (NYSE: MO), kunye ne-Leggett (NYSE: LEG) yi-blue-chip stocks enye.Umzekelo, i-Unilever ihlawula i-2.02 yeedola ngesabelo ngonyaka, okuthetha ukuba kufuneka uthenge izabelo ezingama-495, kwaye kuya kubiza phantse i-26,000 yeedola ukuthenga isitokhwe ngexabiso le-stub elingaphezulu kwe-52 yeedola.
UMlawuli oLawulayo we-Cowen uKevin Kopelman uzibandakanye ne-Yahoo Finance ukuze aphule ukukhula okungazange kubonwe ngaphambili kwe-Airbnb, okukhokelele ekuphuculweni kwe-Cowen, ubungqina obuxhasa olu hlaziyo, kunye nemeko yokhuphiswano lweshishini lehotele.
Faka isicelo sekhadi letyala leAmerican Express Explorer™ Apha ukonwabele umrhumo wonyaka wokuqala kunye namanqaku ayi-3 asimahla, ukuthenga ngobuchule okanye ukulungisa imivuzo eyahlukeneyo yokuchitha!
Emva kokuba umhlalutyi we-Barclays u-Kannan Venkateshwar egcine ukulinganisa ubunzima obulinganayo kwisitokisi kwaye yehlisa ixabiso elijoliswe kuyo ukusuka kwi-$ 34 ukuya kwi-30 yeedola, i-AT & T's (NYSE: T) ixabiso le-stock lawa ngoMvulo.Abahlalutyi beBarclays babonise ukuba ngenxa yokusebenza kwempahla enzima ye-Discovery Inc (NASDAQ: DISCA), i-AT & T iya kudibanisa kunye neshishini layo leendaba.Ngexesha lokuqaliswa, i-AT&T yayiyenye yezona zitokhwe ezintathu eziphambili ezihamba phambili kwi-Stocktwits.I-AT&T iya kubhengeza iziphumo zayo zemali kwikota yesithathu
Abaxhasi bethu abathathu babonelele ngezitokhwe ezintathu ze-COVID-19, eziya kunyuka nokuba siphuma kulo bhubhani.
Ingxelo yemveliso ye-iPhone ye-Apple yabangela ukuba ikamva liwe.Ngaphandle kwamanyathelo aqatha athatyathwe ngu-Upstart kunye nabantu abaninzi, imakethi iphinde yaphinda yavala kwaye yavalwa kakubi.
Abathengi abakhethiweyo bafaka isicelo se-12-36 ixesha lokubuyisela kwaye imali yi-$ 200,000 okanye ngaphezulu, kwaye inzala yonyaka eyi-4% imiselwe!Ukuboleka ukuboleka?Kwakhona fumana imali mboleko elungileyo!
I-ARK Invest iyaqhubeka ukongeza ezinye zeependants ezinkulu ze-CEO uCasey Wood, kubandakanywa ipendenti eziwele phantse ngama-60% okoko kwanda ngoFebruwari.
Amabali ahlekisayo (okanye alusizi, kuxhomekeke kwindlela oyijonga ngayo) amabali amafutshane akwiveki ephelileyo aya kukukhuthaza (ngethemba) ukuba ujonge kabini ipotifoliyo yakho njengoko singena ngo-2022.
Umenzi we-chip ohambahambayo uthe ibhodi yakhe yabalawuli ivume inkqubo entsha yokuthenga i-10 yeebhiliyoni zeedola, eya kusebenza ngokukhawuleza.
Ukusukela ngoku kude kube nge-24 ka-Okthobha ngo-2021, ukhetho olukhulu luka-Ernst & Young lwezinto ezibandakanya iimpahla zasekhaya kunye nempahla yabasetyhini ziya kunikwa ngesaphulelo ukuya kuthi ga kwi-20%, ngokukhawuleza uqalise izinto ezizithandayo!
Uxwebhu lubonisa ukuba i-dividend edibeneyo yeenkampani ezimbini ezizimeleyo aziyi kuba ngaphantsi kwe-dividend ngaphambi kokuhlukana kwe-IBM.
(Bloomberg)-Bloomberg ingxelo yokuba isigebenga setekhnoloji sinokuyinqumla i-2021 ye-iPhone 13 ekujoliswe kuyo ngenxa yokunqongophala kwe-chip, kwaye yacaphula abantu abaqhelene nalo mbandela besithi abathengisi be-Apple bawa ngoLwesithathu.Umjikelo othobekileyo waba ngubugcisa obubonisa umgca ongaphambili womzabalazo wokuqhomfa eKentucky, eMelika.Ngoku kukhangeleka ngathi iWaldorf Astoria yaseNew York ihlaziywa kanobom, ibe luphawu lwetycoon yaseTshayina engaphaya kwengozi yezindlu ngexesha lobunzima.
Emva kokuba iteknoloji yezobuchwephesha iphakamise izibikezelo zabo zemali ezipheleleyo, i-InMode (NASDAQ: INMD) izabelo zenyuka nge-8.6% ngoLwesibili.Ke ngoko, i-InMode ilindele ingeniso yeedola ezingama-93 kwikota yesithathu.
Iqela lootitshala elikwi-Intanethi okanye lomzimba, elilungele lonke ubhaliso lobungcali, imisebenzi yenkcubeko yasimahla ngamaxesha athile, amava amasiko ahlukeneyo esizwe, iPrince Tuen Mun Yuen Long Tin Shui Wai Sha Tin Wind Class!
Esi sitokhwe se-biotech, esiye safumana ukuguquguquka kuphela, yintandokazi yabatyali-mali abathengisayo ngenxa yamandla okukhawuleza okufutshane.
U-Aadil Zaman, ihlakani le-Wall Street Alliance Group, usasazwa ngqo kwi-Yahoo Finance, exoxa ngezinto ezilindelweyo kwikota yesithathu yonyaka wengeniso, iibhanki ezinkulu kunye nokuvuselelwa koqoqosho.
Ixesha lokuposa: Oct-13-2021